Enceladus is a drug development company that introduces Nanocort, a liposomal pharmaceutical that contains anti-inflammatory corticosteroid and selectively targets the actual sites of pathology in severe inflammatory disorders such as rheumatoid arthritis (RA) and multiple sclerosis (MS), and in cancer.
